Medicxi Ventures Management (Jersey) LTD Centessa Pharmaceuticals PLC Transaction History
Medicxi Ventures Management (Jersey) LTD
- $353 Million
- Q2 2025
A detailed history of Medicxi Ventures Management (Jersey) LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Medicxi Ventures Management (Jersey) LTD holds 19,963,157 shares of CNTA stock, worth $319 Million. This represents 74.33% of its overall portfolio holdings.
Number of Shares
19,963,157
Previous 19,963,157
-0.0%
Holding current value
$319 Million
Previous $291 Million
9.94%
% of portfolio
74.33%
Previous 75.25%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
138Shares Held
124MCall Options Held
163KPut Options Held
816K-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$159 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$155 Million4.7% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.95MShares$111 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$94.5 Million0.05% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.34MShares$85.3 Million0.01% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.51B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...